GSK plc

GSK plc
	Head office in Brentford, London with the former GlaxoSmithKline logo, taken in July 2007
Formerly	GlaxoSmithKline (2000–2022)
Type	Public
Traded as	LSE: GSK; FTSE 100 Component;
Industry	Pharmaceutical; Biotechnology;
Predecessors	Glaxo Wellcome; SmithKline Beecham;
Founded	27 December 2000; 24 years ago
Headquarters	London, England, UK
Area served	Worldwide
Key people	Sir Jonathan Symonds (chairperson); Emma Walmsley (CEO);
Products	Pharmaceutical drugs; vaccines;
Revenue	GB£31.376 billion (2024)
Operating income	GB£4.021 billion (2024)
Net income	GB£2.951 billion (2024)
Total assets	GB£59.463 billion (2024)
Total equity	GB£13.086 billion (2024)
Number of employees	70,000 (2025)
Subsidiaries	Stiefel Laboratories; Tesaro; ViiV Healthcare (76.5%);
Website	www.gsk.com

GSK plc, which used to be called GlaxoSmithKline plc. It is a multinational drug and biotechnology company with global headquarters in London, It is the is the tenth largest drug company.

It was started in 2000 when Glaxo Wellcome and SmithKline Beecham joined together. Its market capitalisation was £60 billion in May 2023. ^[3]

It made the first malaria vaccine in 2014.^[4]

GSK Plc Media

The Glaxo factory in Bunnythorpe, New Zealand, built in 1918, with the Glaxo Laboratories sign still visible
Feeder bottle with valve and teat, Glaxo Laboratories, Greenford, Middlesex
Beecham's Clock Tower, constructed 1877, part of the Beecham's factory, St Helens
Andrew Witty, GSK's CEO from May 2008, to April 2017

2, strength: 2 mg, color: pink, size: 10 mm (0,39″), shape: five-sided, availability: ℞-only, CSA schedule: not a controlled drug, drug class: thiazol

Paroxetine, known as Paxil and Seroxat

References

↑ ^1.0 ^1.1 ^1.2 ^1.3 ^1.4 "Preliminary Results 2024" (PDF). GSK. Retrieved 9 February 2025.
↑ "At a glance". GSK. Retrieved 9 February 2025.
↑ "FTSE All-Share Index Ranking". www.stockchallenge.co.uk. Retrieved 2023-05-20.
↑ Plumridge, Hester (2014-07-24). "Glaxo Files Its Entry in Race for a Malaria Vaccine" (in en-US). Wall Street Journal. ISSN 0099-9660 . http://online.wsj.com/articles/glaxo-files-its-entry-in-race-for-a-malaria-vaccine-1406218538. Retrieved 2023-05-20.

Template:British royal warrant holders

[results-1] 1.0 ^1.1 ^1.2 ^1.3 ^1.4 "Preliminary Results 2024" (PDF). GSK. Retrieved 9 February 2025.

[2] "At a glance". GSK. Retrieved 9 February 2025.

[3] "FTSE All-Share Index Ranking". www.stockchallenge.co.uk. Retrieved 2023-05-20.

[4] Plumridge, Hester (2014-07-24). "Glaxo Files Its Entry in Race for a Malaria Vaccine" (in en-US). Wall Street Journal. ISSN 0099-9660 . http://online.wsj.com/articles/glaxo-files-its-entry-in-race-for-a-malaria-vaccine-1406218538. Retrieved 2023-05-20.

[1]

[2]

[3]

[4]